We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 35.71%
2 Technology 14.95%
3 Financials 13.65%
4 Communication Services 11.15%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOKM.U
201
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$2.5M 0.01%
+250,000
New +$2.55M
HIIIU
202
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
$2.48M 0.01%
+250,000
New +$2.51M
SNII.U
203
DELISTED
Supernova Partners Acquisition Company II, Ltd. Units, each consisting of one Class A ordinary share
SNII.U
$2.01M 0.01%
+200,000
New +$2.03M
ANAC.U
204
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
$2M 0.01%
+200,000
New +$2.02M
VPCBU
205
DELISTED
VPC Impact Acquisition Holdings II Unit
VPCBU
$1.97M 0.01%
+200,000
New +$2M
BRMK.WS
206
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$1.64M 0.01%
7,174,613
– –
LDHAU
207
DELISTED
LDH Growth Corp I Units
LDHAU
$1.52M 0.01%
+150,000
New +$1.51M
PMGMU
208
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$1.49M 0.01%
+150,000
New +$1.52M
TMAC.U
209
DELISTED
The Music Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TMAC.U
$1.25M 0.01%
+125,000
New +$1.29M
NSTC.U
210
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$995K ﹤0.01%
+100,000
New +$1M
NSTD.U
211
DELISTED
Northern Star Investment Corp. IV Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTD.U
$992K ﹤0.01%
+100,000
New +$998K
CFVIU
212
DELISTED
CF Acquisition Corp. VI Unit
CFVIU
$990K ﹤0.01%
+100,000
New +$1.01M
FOLD
213
DELISTED
Amicus Therapeutics
FOLD
$988K ﹤0.01%
100,000
-1,150,000
-92% -$17.8M
ASPCU
214
DELISTED
Alpha Capital Acquisition Co Unit
ASPCU
$792K ﹤0.01%
+79,598
New +$811K
TINV.WS
215
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$702K ﹤0.01%
+540,000
New +$999K
SLAMU
216
DELISTED
Slam Corp. Unit
SLAMU
$699K ﹤0.01%
+70,508
New +$711K
GOL
217
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$657K ﹤0.01%
85,838
– –
SPAQ.U
218
DELISTED
Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo
SPAQ.U
$602K ﹤0.01%
+60,053
New +$623K
CEREW
219
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$566K ﹤0.01%
134,175
– –
CAS.WS
220
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$446K ﹤0.01%
+495,000
New +$649K
HMCOW
221
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$264K ﹤0.01%
+200,000
New +$410K
EMBKW
222
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$107K ﹤0.01%
+92,675
New +$148K
SVFAW
223
DELISTED
SVF Investment Corp. Warrant
SVFAW
$104K ﹤0.01%
+50,000
New +$194K
ABBV icon
224
AbbVie
ABBV
$468B
– –
-1,150,000
Closed -$123M
BMY icon
225
Bristol-Myers Squibb
BMY
$137B
– –
-250,000
Closed -$15.5M
6 7 8
9
10

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2021 Portfolio in Review

As of Q1 2021, Thomas Steyer held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Thomas Steyer deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Thomas Steyer's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Thomas Steyer's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Thomas Steyer fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Thomas Steyer's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Thomas Steyer opened 120 new positions and closed 20 in Q1 2021.
  • Thomas Steyer's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.